SCHEDULE 13G/A Filing for Illumina Inc. by The Vanguard Group
2026-03-27SEC Filing SCHEDULE 13G/A (0000102909-26-001552)
This filing is an amendment to a previous filing by The Vanguard Group, Inc. concerning their ownership of Illumina Inc. common stock. As of March 13, 2026, The Vanguard Group, Inc. has reported beneficial ownership of 0 shares, representing 0% of the class. This indicates a significant change from previous holdings, likely due to an internal realignment effective January 12, 2026. Following this realignment, certain subsidiaries and business divisions of The Vanguard Group, Inc. will now report their beneficial ownership separately. The Vanguard Group, Inc. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
Related industry:Diagnostics & Research
Source:Original SEC Document β